Navigation Links
OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
Date:3/16/2010

ARLINGTON, Texas, March 16 /PRNewswire/ -- OrthoAccel Technologies, Inc. is among the over 100 companies and technology innovators from across the nation and around the world that will compete for top honors at the WBT2010, March 16-17 in Arlington-DFW, Texas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

OrthoAccel's AcceleDent System, an acceleration device to enhance orthodontics, will be rigorously prepped by WBTshowcase commercialization experts to present to participants including venture capitalists and Fortune 1000 licensees. Over 500 professionals attended last year's event.

"The conventional wisdom for venture capital is that a down economy can be a great time to invest," said Paul Huleatt, WBTshowcase CEO. "The pace of new innovations accelerates, the best deals rise quickly to the top and sophisticated investors receive great value for their money."

According to Mr. Huleatt, one in three WBTshowcase presenters goes on to secure venture funding, license their technology, or sell their IP outright, representing over $450 million raised to date.

Michael Lowe, CEO of OrthoAccel, commented, "We are committed to building the AcceleDent brand around the customer above all else." Michael Kaufman, VP Business Development and Marketing for OrthoAccel remarked, "Introducing a new product category will come with many challenges; launching innovation always does. An exciting benefit of AcceleDent is that it can be used to enhance orthodontic treatment of any approach, regardless of the type of appliance or profile of patient."

Mr. Huleatt highlighted that the companies groomed to present at the WBTshowcase leave with new knowledge and contacts to take their technologies to the market and beyond.

OrthoAccel is nearing conclusion of another US clinical trial at the UT Health Science Center in San Antonio with an anticipated completion date during the first half of 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com

About WBTshowcase

The WBTshowcase is the nation's premier event showcasing the largest collection of undiscovered technologies emanating from the world's leading universities, labs and research institutions. The 2010 WBTshowcase will be held March 16-17 in Arlington-DFW, Texas. www.wbtshowcase.com

Media Contact Michael K. Lowe, CEO +1 (281) 798-5318

SOURCE OrthoAccel Technologies, Inc.

Back to top

RELATED LINKS
http://www.acceledent.com

'/>"/>

SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
5. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
8. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
9. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
10. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
11. Orchid Cellmark to Purchase ReliaGene Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Columbia , April 27, 2016 ... "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... Anschluss an ihre Pressemitteilung vom 13. August 2015 ... hat, ihre Finanzen um zusätzliche 200.000.000 Einheiten auf ... Kanadische Dollar zu bringen. Davon wurden 157.900.000 Einheiten ...
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., a leading ... Dr. Lamka will assist PathSensors in expanding the use of the company’s CANARY® ... CANARY® test platform for the detection of harmful pathogens, including a number of ...
(Date:4/27/2016)... , April 27, 2016 MedDay, ... disorders, today announces the appointment of Catherine Moukheibir as Chairman ... MedDay,s previous Chairman, Jean Jacques Garaud , who contributed ... change is effective immediately. Catherine started her career ... and London .  She held ...
(Date:4/26/2016)... ... 26, 2016 , ... The European Patent Office (EPO) today announced ... finalists for the European Inventor Award 2016 in the category "Non-European countries." The winners ... a ceremony in Lisbon on June 9th. , The human capacity to walk with ...
Breaking Biology Technology:
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/10/2016)... PUNE, India , March 10, 2016 ... to a new market research report "Identity and Access ... SSO, & Audit, Compliance, and Governance), by Organization Size, ... Forecast to 2020", published by MarketsandMarkets, The market is ... to USD 12.78 Billion by 2020, at a Compound ...
Breaking Biology News(10 mins):